This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Dec;14(12):815-6.

doi: 10.1038/nrd4793. Epub 2015 Nov 20.

Two decades of new drug development for central nervous system disorders

Aaron S Kesselheim¹, Thomas J Hwang², Jessica M Franklin¹

Affiliations

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA.
² Harvard University, Cambridge, Massachusetts, and Bain Capital, Boston, Massachusetts 02116, USA.

PMID: 26585536
DOI: 10.1038/nrd4793

Two decades of new drug development for central nervous system disorders

Aaron S Kesselheim et al. Nat Rev Drug Discov. 2015 Dec.

. 2015 Dec;14(12):815-6.

doi: 10.1038/nrd4793. Epub 2015 Nov 20.

Authors

Aaron S Kesselheim¹, Thomas J Hwang², Jessica M Franklin¹

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA.
² Harvard University, Cambridge, Massachusetts, and Bain Capital, Boston, Massachusetts 02116, USA.

PMID: 26585536
DOI: 10.1038/nrd4793

No abstract available

PubMed Disclaimer

Similar articles

Is pharma running out of brainy ideas?
Miller G. Miller G. Science. 2010 Jul 30;329(5991):502-4. doi: 10.1126/science.329.5991.502. Science. 2010. PMID: 20671165 No abstract available.
Securing the future of drug discovery for central nervous system disorders.
Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A; 2013 CINP Summit Group. Andersen PH, et al. Nat Rev Drug Discov. 2014 Dec;13(12):871-2. doi: 10.1038/nrd4489. Nat Rev Drug Discov. 2014. PMID: 25435203
Regulatory watch: Challenges in drug development for central nervous system disorders: a European Medicines Agency perspective.
Butlen-Ducuing F, Pétavy F, Guizzaro L, Zienowicz M, Haas M, Alteri E, Salmonson T, Corruble E. Butlen-Ducuing F, et al. Nat Rev Drug Discov. 2016 Nov 29;15(12):813-814. doi: 10.1038/nrd.2016.237. Nat Rev Drug Discov. 2016. PMID: 27895328 No abstract available.
A need for speed: Signals in drug development.
[No authors listed] [No authors listed] Nat Med. 2012 Dec;18(12):1730-1. doi: 10.1038/nm1212-1730. Nat Med. 2012. PMID: 23223053 Review. No abstract available.
Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.
Cole PE, Schwarz AJ, Schmidt ME. Cole PE, et al. Clin Pharmacol Ther. 2012 Feb;91(2):315-20. doi: 10.1038/clpt.2011.286. Epub 2012 Jan 4. Clin Pharmacol Ther. 2012. PMID: 22218072 Review.

See all similar articles

Cited by

New epilepsy therapies in development.
Klein P, Kaminski RM, Koepp M, Löscher W. Klein P, et al. Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22. Nat Rev Drug Discov. 2024. PMID: 39039153 Review.
Trends in mental health clinical research: Characterizing the ClinicalTrials.gov registry from 2007-2018.
Wortzel JR, Turner BE, Weeks BT, Fragassi C, Ramos V, Truong T, Li D, Sahak O, Lee HB. Wortzel JR, et al. PLoS One. 2020 Jun 5;15(6):e0233996. doi: 10.1371/journal.pone.0233996. eCollection 2020. PLoS One. 2020. PMID: 32502181 Free PMC article.
Epigenetic editing for autosomal dominant neurological disorders.
Waldo JJ, Halmai JANM, Fink KD. Waldo JJ, et al. Front Genome Ed. 2024 Mar 6;6:1304110. doi: 10.3389/fgeed.2024.1304110. eCollection 2024. Front Genome Ed. 2024. PMID: 38510848 Free PMC article. Review.
Individualized functional brain mapping machine learning prediction of symptom-change resulting from selective kappa-opioid antagonism in an anhedonic sample from a Fast-Fail trial.
Sacchet MD, Valenti JL, Keshava P, Walsh SW, Smoski MJ, Krystal AD, Pizzagalli DA. Sacchet MD, et al. J Mood Anxiety Disord. 2025 May 9;11:100126. doi: 10.1016/j.xjmad.2025.100126. eCollection 2025 Sep. J Mood Anxiety Disord. 2025. PMID: 40657347 Free PMC article.
Computational perspectives on human fear and anxiety.
Yamamori Y, Robinson OJ. Yamamori Y, et al. Neurosci Biobehav Rev. 2023 Jan;144:104959. doi: 10.1016/j.neubiorev.2022.104959. Epub 2022 Nov 11. Neurosci Biobehav Rev. 2023. PMID: 36375584 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database